← FDA Drug Approvals (Drugs@FDA)

RIVASTIGMINE TARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2007-10-22

Drug application

FDA Application #

ANDA077131

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIVASTIGMINE TARTRATE

Generic name

RIVASTIGMINE TARTRATE

Active ingredients

RIVASTIGMINE TARTRATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

SUN PHARM

Manufacturer

Sun Pharmaceutical Industries, Inc.

First approval

2007-10-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown